This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

276 result(s)

Ellipta inhaler

27-11-2015
Ellipta inhaler information for UK healthcare prpfessionals including getting started, how to use the Ellipta inhaler and top tips for your patients.

Incruse▼ Ellipta

21-11-2015
Incruse▼ (umeclidinium bromide inhalation powder) product information and resources to support UK healthcare professionals in their daily practice.

Sitemap

GlaxoSmithKline (GSK) UK healthcare professional website site map.

DECTOVA

Zanamivir IV</br> Influenza

Supply

Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability

Dectova

Zanamivir IV<br/> Influenza

Dectova

Zanamivir IV<br/> Influenza

Falsified Medicines Directive

Information to support UK healthcare professionals on the falsified medicines directive in relation to GSK medicines and vaccines.

Homepage

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Therapy areas

GSK UK therapy areas page allows healthcare professionals to find GSK product information by therapy area.

COPD expert perspectives

Watch GSK Global Medical Experts approach key issues in COPD treatment, offering solutions for UK healthcare professionals.

COPD

Overview of COPD

Commissioning

Resources to support commissioners and healthcare professionals when making an asthma or COPD formulary application.

Planning and Implementation

Information to support commissioners and healthcare professionals plan and implement an Ellipta asthma or COPD guidelines.

Setting the record straight

Read about why we (GSK) share our trials results regardless of whether they reflect positively or negatively on our medicines.

ERS 2018

Watch video highlights from this year's ERS Conference

Respiratory

Overview of Asthma and COPD

Asthma expert perspectives

Watch GSK Global Medical Experts approach key issues in asthma treatment, offering potential solutions for you and your patients

Asthma

Overview of Asthma

Severe Asthma

Overview of severe asthma

Ellipta critical error studies in asthma

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their asthma patients

Ellipta critical error studies in COPD

Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients

Expert Perspectives | Ellipta device | Respiratory | GSKpro

webpage to host device related video content from webinars

Healthcare in your pocket

Healthcare in your pocket - Read about the work GSK is involved in with digital technology such as the development of apps like MyAsthma.

Vaccines

GSK UK information about our vaccines and disease awareness campaigns

Vaccines – frequently asked questions

Answers to frequently asked questions about GSK Vaccines

Ordering and delivery

Find out how to set up an account and start ordering GSK vaccines.

Seretide Accuhaler and Ventolin Accuhaler recall

Seretide Accuhaler and Ventolin Accuhaler product recall information for UK healthcare professionals

Contact us

GSK UK contact page for healthcare professionals

Request a contact

Contact us form for UK healthcare professionals to contact GSK

Report Adverse Event

Form for UK healthcare professionals to report an adverse event related to a GSK product

device

Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video

guidelines

Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children

Avamys Overview

Avamys topic index: request, indications, patients, device, efficacy, action, guidelines

safety

Avamys safety in adults and children: well-tolerated, common AE, bioavailability, rapid clearance, no mucosal atrophy, no effect on lower leg growth rate

management-of-AR

Avamys Videos: Avamys device, patient preference study, AR management, efficacy

videos

Avamys Videos: Avamys device, patient preference study, AR management, efficacy

efficacy

Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video

indication

Avamys indications: adult patients with moderate-to-severe perennial AR, seasonal AR, and moderate AR with asthma; pediatric patient

COPD Guidelines and Guidance

Incruse▼ (umeclidinium bromide inhalation powder) COPD guidance and guidelines to support UK healthcare professionals in their daily practice.

Indications

Incruse▼ (umeclidinium bromide inhalation powder) indication information to support UK healthcare professionals in their daily practice.

Guidelines

This page is currently under review.

Toctino▼

Toctino (alitretinoin) information and resources to support UK healthcare professionals in their daily practice.

Living with severe chronic hand eczema

This page is currently under review.

Pregnancy prevention programme

Toctino (alitretinoin) pregnancy prevention programme information and resources to support UK healthcare professionals in their daily practice.

Products

GSK product information for UK healthcare professionals

Administration and storage

Varilrix – Chickenpox/varicella vaccine administration and storage information to support UK healthcare professionals

Indications and dosage

Varilrix – Chickenpox/varicella vaccine indications and dosage information to support UK healthcare professionals

Efficacy and effectiveness

Varilrix – Chickenpox/varicella vaccine efficacy and effectiveness information to support UK healthcare professionals

Varilrix

Varilrix – Chickenpox/varicella vaccine product information to support UK healthcare professionals

Safety

Varilrix – Chickenpox/varicella vaccine safety information to support UK healthcare professionals

Mode of action

Bexsero Meningitis B vaccine mode of action information for UK healthcare professionals

Invasive Meningococcal Disease

Bexsero Meningitis B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD)

Epidemiology

Bexsero Men B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD) epidemiology

Transmission and symptoms

Bexsero Meningitis B vaccine transmission and symptoms information for UK healthcare professionals

Bexsero

Bexsero Meningitis B vaccine information for UK healthcare professionals

Bexsero Overview

Bexsero Meningitis B vaccine overview for UK healthcare professionals

List price reduction

Learn about the list price reductions on some packs of the Seretide range

Clinical evidence

Clinical evidence to support UK Healthcare professionals in the use of Seretide for asthma and COPD.

Seretide in younger patients

Find out how Seretide could be used to treat the symptoms of asthma in paediatric patients aged four and above.

Why Seretide?

Find out about the benefits of prescribing Seretide for your asthma/COPD patients.

Seretide inhaler technique and safety

Videos and materials to help you ensure your patients are using their Seretide Accuhaler and Evohaler correctly.

Seretide rebates and savings

Learn about the immediate savings you could make by signing up to our Seretide rebate.

Adartrel

Adartrel (ropinirole hydrochloride) - links to the summary of product characteristics, patient information leaflet and supply information to support UK healthcare professionals.

How to prescribe

An overview of Duac 5% and Duac 3% formulation, strength, indications and how to prescribe Duac

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Guidelines

An overview of the EDF guideline recommendations and the role of Duac in the treatment of acne

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro

Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals

Augmentin Duo

Information on the discontinuation of Augmentin Duo Strawberry Flavour and the replacement of Augmentin Duo Mixed Fruit Flavour

Trelegy▼ Ellipta

Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) product information & resources to support UK healthcare professionals in their daily practice.

Efficacy and safety

Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) efficacy and safety information to support UK healthcare professionals.

Quality of Life (IMPACT)

Health-related QoL efficacy results for TRELEGY Ellipta

Efficacy

Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.

Lung Function (IMPACT)

Lung Function efficacy results for TRELEGY Ellipta

Exacerbations (IMPACT)

Exacerbation efficacy results for TRELEGY Ellipta.

Formulary support

Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) formulary support information to support UK healthcare professionals.

Zovirax

Information on the discontinuation of Zovirax (aciclovir) eye ointment 3% 4.5g for UK healthcare professionals

AeroChamber Plus

The distribution of AeroChamberPlus* has transferred from GSK UK Ltd to Trudell Medical UK as of 21st December 2017.

Amoxil

Information on the discontinuation of Amoxil and Amoxil capsules for UK healthcare professionals

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

Show more